Close
This site uses cookies

By using this site, you consent to our use of cookies. You can view our terms and conditions for more information.

Return to Session

An application of a hierarchical diffusion model on ambulatory data from Huntington's patients

Authors
Brendan McLaren
Monash University, Australia
Mr. Ricky Romeu
Indiana University Bloomington ~ Cognitive Science
Sophie Andrews
Monash University, Australia
Julie Stout
Monash University, Australia
Abstract

Huntington's disease is a debilitating neurodegenerative illness involving motor and cognitive impairments throughout its progression, eventually leading to death. Diagnosis is based on motor symptoms; however, the cognitive symptoms are more debilitating. Assessing the disease's consequences on cognition can hint at what processes should be targeted for cognitive-behavioral treatment. We present an application of a hierarchical diffusion model (Ratlciff et al., 2016; Vandekerchkove et al., 2010) to an ambulatory assessment with manifest (HD) and premanifest (PM) Huntington's patients and compare their performance, as assessed by the model, to performance from controls on a numerosity task (McLaren et al., 2020). We found a gradation of impairment across the groups in the mean drift rate, such that: (1) HD always had a lower drift rate than controls; (2) HD had lower drift rates than PM in the "easy" condition, but they had essentially equivalent rates in the "difficult" condition; (3) PM had lower drift rates than controls in the "difficult" condition, but they had essentially equivalent rates in the "easy" condition. These results held even after regressing on age for all groups, and were not observed when analyzing average response times or correct/incorrect response percentages. Our Bayesian approach also allowed us to assess which parameters were most reliably estimated with ambulatory data through the Gelman-Rubin statistic. Overall, we found that the hierarchical diffusion model provided novel insights into the progression of Huntington's disease, with our Bayesian model providing a powerful method of assessment and group separation even with in-home, ambulatory data on mobile phones.

Tags

Keywords

Huntinton's Disease
Cognitive Modeling
Diffusion Model
Bayesian Modeling
Clinical Modeling

Topics

Cognitive Modeling
Decision Making
Reaction Times
Bayesian Modeling
Accumulator/Diffusion models
Discussion
New

Hello Ricky: Very nice presentation--crystal clear on both conclusions that can be validly drawn as well as candor on challenges involved in this type of work. Well done! Jim

James T. Townsend 0 comments